mRNA vaccine inventor suggests collusion between CNN,

New Post Public Reply Private Reply Replies (1) Message Board
energy_wave energy_wave #72496
666
mRNA vaccine inventor suggests collusion between CNN, Pfizer

Quote:
OAN Newsroom
UPDATED 2:09 PM PT – Friday, November 12, 2021

The inventor of messenger RNA (mRNA) vaccines has sounded the alarm over potential collusion between CNN and Pfizer. Dr. Robert Malone deconstructed a CNN segment featuring the network’s chief correspondent and Sesame Street’s Big Bird.

Dr. Malone said he believes Pfizer is using CNN as a surrogate to advertise directly to children, driving consumer demand to cause the Centers for Disease Control and Prevention (CDC) to purchase additional unlicensed vaccines. He said not only does this constitute illegal marketing of an unlicensed pharmaceutical product, but may also meet the criteria for corrupt racketeering.

https://www.oann.com/mrna-vaccine-inventor-su...nn-pfizer/


He maintained Pfizer is pushing for vaccinations while the drug is still in its emergency authorization status because pharmaceutical companies will not be held liable for an experimental medication.

“Coverage that allows Pfizer to not be held liable for any adverse events only applies to the Pfizer product, which is still under emergency use authorization,” said Malone.

Additionally, Malone contended that Pfizer circumvented the normative Food and Drug Administration (FDA) process, evading the conventional peer-reviewed period in order to meet mandate standards and the true efficacy rates dip into the 40 percent range as studies out of Israel suggest.

“What I think they’ve done here is jam something through that will enable the government and commercial entities and states to mandate vaccines to the military and otherwise. But by their own statements they don’t have the data to support the safety and efficacy claims,” said Malone. “The claims they do have are completely outdated. It’s based on the alpha and beta variants.”

Dr. Malone has also questioned why corporate media outlets censure ivermectin despite its worldwide use and long-held benefits.

Meanwhile, CNN has continued to peddle its anti-ivermectin agenda, falsely labeling the medication as a horse de-wormer. In an effort to promote vaccines and suppress alternatives, the network has leveled attacks against high-profile figures with large platforms who even suggest ivermectin as a legitimate therapy.

The most recent subjects of these attacks have been podcaster Joe Rogan and quarterback Aaron Rodgers. CNN aired numerous segments ridiculing the athlete for speaking out on his personal health decisions, calling it a dangerous use of his platform.


Despite CNN’s best efforts to discredit ivermectin, the CDC itself lists the drug as an integral part of its program for U.S. bound refugees. It also recommends it as a presumptive therapy for all refugees originating from the Middle East, North Africa and Latin America.

In response to the backlash, CNN issued a statement that not only ignored Gutpa’s admission, but also doubled down. The mainstream media outlet alleged a powerful voice in media like Rogan was promoting the use of “an unproven treatment for COVID-19 and a drug developed to ward off parasites in farm animals.”

Dr. Malone’s suggestion of collusion between CNN and Pfizer may explain the corporate media’s determined push for vaccines and mandates while discrediting any alternatives.


https://www.oann.com/mrna-vaccine-inventor-su...nn-pfizer/
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 5

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 2

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 15

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Montessori and Tech: A New Era of Integration

Updated Category News Views 16

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 9

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 17

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 15

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 2

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 14

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading

Top 5 Most Recently Viewed Articles

Jon Acuff to Inspire at GS1 Connect 2025 Conference

Updated Category News Views 307

Jon Acuff to Inspire at GS1 Connect 2025 Conference Three-Day Conference to Share Supply Chain Best Practices Leveraging GS1 Standards to Drive Innovation Jon Acuff, a bestselling author renowned for his engaging speaking style and insightful perspectives, will keynote at GS1 Connect 2025, a live three-day event scheduled for June 10-12, 2025, at the Gaylord Opryland...

Continue Reading
Cardo AI Secures $15 Million Funding to Elevate Financing Tech

Updated Category News Views 184

Cardo AI Secures Significant Funding for Growth Cardo AI, an innovative platform focused on asset-based finance and private credit, has successfully completed a $15 million Series A funding round. This impressive fundraising effort was co-led by Blackstone Innovations Investments, FINTOP Capital, and JAM FINTOP. The financial backing will enable Cardo AI to broaden its...

Continue Reading
Actress Nathalie Kelley's Unique Jewelry to Combat Mercury

Updated Category News Views 265

Actress Nathalie Kelley's Unique Jewelry to Combat Mercury Nathalie Kelley, the talented actress known for her captivating performances in films and series such as Fast and Furious: Tokyo Drift and The Vampire Diaries, has taken on a new role as an advocate for sustainable gold mining. In her latest initiative, she designed a stunning jewelry piece to raise awareness...

Continue Reading
Simpson Manufacturing Co's Upcoming Earnings Expectations

Updated Category News Views 70

Anticipating Simpson Manufacturing Co's Earnings Results As Simpson Manufacturing Co (NYSE: SSD) approaches the date to announce its quarterly earnings, investors are keenly interested in the implications of this report. Scheduled for a release soon, there are several important factors to consider that may influence investor decisions. Analysts are projecting an earnings...

Continue Reading
LoJack and Zeigler Auto Group Unite for NASCAR Adventure

Updated Category News Views 53

LoJack Joins Forces with Zeigler Auto Group Excitement is building as LoJack, a leader in stolen vehicle recovery solutions, partners with Zeigler Auto Group to co-sponsor Spire Motorsports' No. 77 Camaro. This dynamic duo will take the track at the prestigious NASCAR Cup Series Race at Homestead-Miami Speedway. The renowned driver Carson Hocevar, a strong contender for...

Continue Reading